Señales en vivo de HCWB | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 16:00):

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases...

Stats
Volumen de hoy	6 199.00
Volumen promedio	15 947.00
Capitalización de mercado	48.41M
EPS	$-0.300 ( 2024-04-01 )
Próxima fecha de ganancias	( $0 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.830
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-20	Wong Hing C	Buy	739 288	Common Stock
2024-02-20	Greene Rick S.	Buy	35 714	Common Stock
2024-02-20	Giles Lisa M.	Buy	35 715	Common Stock
2024-02-20	Garrett Scott T	Buy	142 858	Common Stock
2024-02-20	Flowers Lee	Buy	71 429	Common Stock

INSIDER POWER
92.29
Last 100 transactions
Buy: 3 866 595 \| Sell: 3 743 515

HCW Biologics Inc. Correlación

10 Correlaciones Más Positivas
BRKR	0.938
GRMN	0.933
IMGN	0.932
TRVI	0.927
EBIZ	0.926
FRPT	0.926
NXGN	0.926
STRL	0.926
APLT	0.925
BLU	0.924

10 Correlaciones Más Negativas
MFIN	-0.922
BCOR	-0.917
AMTBB	-0.905
TZPS	-0.903
SABR	-0.902
PEAR	-0.901
GLLI	-0.899
LCYAU	-0.894
VORB	-0.893
MCAA	-0.893

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

HCW Biologics Inc. Finanzas

Annual	2023
Ingresos:	$2.84M
Beneficio Bruto:	$-574 824 (-20.23 %)
EPS:	$-0.700

FY	2023
Ingresos:	$2.84M
Beneficio Bruto:	$-574 824 (-20.23 %)
EPS:	$-0.700

FY	2022
Ingresos:	$6.72M
Beneficio Bruto:	$2.59M (38.48 %)
EPS:	$-0.410

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.527

Financial Reports:

No articles found.

HCW Biologics Inc.

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.